Press Releases
14 February 2020
SARASOTA, Fla., Feb. 14, 2020 /PRNewswire/ -- GeneTx Biotherapeutics LLC today announced that it has received IRB approval from Rush University Medical Cen
Read more...14 February 2020
CHARLOTTESVILLE, Va., Feb. 14, 2020 /PRNewswire/ -- Caretaker Medical, a leader in clinical-grade wireless patient monitoring and maker of the Caretaker® wearable patient monitor that utilizes a simple Finger Cuff to measure Real-time "Beat by Beat" Continuous Blood Pressure, Respiration Rate, and other hemodynamic parameters, has incorporated VivaLNK's FDA-Cle
Read more...14 February 2020
DALLAS, Feb. 14, 2020 /PRNewswire/ -- December 2019 marked a significant milestone when Absolute Nature CBD (https://absolutenaturecbd.com) unexpectedly rece
Read more...BURLINGTON, Ontario, Feb. 14, 2020 /PRNewswire/ -- Before being outlawed by most countries in the early part of the 20th century, cannabis had
Read more...EMERYVILLE, Calif., Feb. 14, 2020 /PRNewswire/ -- Biossance, a pioneering clean skincare brand from Amyris, Inc. (NASDAQ: AMRS), a global science and technology leader of pure, sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, is thrilled to announce The Clean Academy, the brand's award-winning educational pla
Read more...SAN DIEGO, Feb. 14, 2020 /PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable info
Read more...STAINES-UPON-THAMES, United Kingdom, Feb. 14, 2020 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, announced today tha
Read more...14 February 2020
NEW HAVEN, Conn., Feb. 14, 2020 /PRNewswire/ -- Kleo Pharmaceuticals, Inc., an immuno-oncology company developing next-generation, fully synthetic bispecific compounds de
Read more...14 February 2020
- Commenced Dosing of Patients in Phase 1 Clinical Trial with INM-755 - VANCOUVER, Feb. 14, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in th
Read more...14 February 2020
VANCOUVER, British Columbia, Feb. 14, 2020 /PRNewswire/ -- NewLeaf Brands Inc. (CSE:NLB) (CSE:NLB.CN) (OTC: NLBIF) (FSE:0NF) ('NewLeaf Brands' or the 'Company') is pleased to announce that is has entered into three distribution agreements (collectively the 'Agreements') with each of HemPup LLC ('HemPup'), Vida Concepts, LLC ('Vida') and NXTGEN, LLC ('NX
Read more...